---
title: "Vland Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 61.78 million yuan, a year-on-year increase of 51.24%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263029694.md"
description: "According to the Zhitong Finance APP, Vland Biotech disclosed its third-quarter report for 2025, stating that the company achieved revenue of 1.016 billion yuan in the first three quarters, a year-on-year increase of 7.42%; net profit attributable to the parent company was 61.78 million yuan, a year-on-year increase of 51.24%; net profit excluding non-recurring items was 22.93 million yuan, a year-on-year decrease of 1.47%; basic earnings per share were 0.24 yuan"
datetime: "2025-10-28T08:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263029694.md)
  - [en](https://longbridge.com/en/news/263029694.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263029694.md)
---

# Vland Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 61.78 million yuan, a year-on-year increase of 51.24%

According to the Zhitong Finance APP, Vland Biotech (603739.SH) disclosed its third-quarter report for 2025. The company achieved revenue of 1.016 billion yuan in the first three quarters, a year-on-year increase of 7.42%; the net profit attributable to shareholders was 61.78 million yuan, a year-on-year increase of 51.24%; the net profit excluding non-recurring items was 22.93 million yuan, a year-on-year decrease of 1.47%; the basic earnings per share were 0.24 yuan

### Related Stocks

- [603739.CN](https://longbridge.com/en/quote/603739.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [ZAWYA: UAE developers accelerate shift to recurring income amid market uncertainty](https://longbridge.com/en/news/287012545.md)
- [Post Oak Energy Capital Announces Sale of UpCurve Energy Assets](https://longbridge.com/en/news/287062130.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)